Back to Peptide Pedia
Immune & Vitality
Well Researched

Thymosin Alpha 1

Tα1

Immune-modulating thymic peptide.

Also known as: Tα1, Zadaxin

Research dose range1.6 mg twice weekly (research models)
Route studiedSubcutaneous
Study durationMulti-week courses
Storage2–8 °C reconstituted

Overview

Thymosin Alpha 1 is a thymic peptide studied extensively in immune-modulation, T-cell function, and host-defense research.

Key research findings

A thymus-derived 28-amino-acid peptide and one of the most clinically validated immune modulators — approved in several countries (as thymalfasin) for hepatitis and as a vaccine adjuvant. Research centers on T-cell maturation and balanced immune-response enhancement.

Mechanism of action

Studied for promoting T-cell maturation and modulating innate and adaptive immune signaling via toll-like receptors.

Molecular information

Weight3,108 Da
Length28 amino acids
TypeThymic immunomodulatory peptide

Acetylated N-terminus; marketed clinically as thymalfasin (Zadaxin).

Pharmacokinetics

Peak: ~2 hoursHalf-life: ~2 hoursCleared: ~24 hours
Peak · 2hHalf-life · 7h

Illustrative relative-concentration model derived from published pharmacokinetic research. Curve is normalized and provided for educational comparison only — not a dosing schedule.

Research applications

  • Immune-modulation research
  • T-cell function studies
  • Host-defense investigations

Research protocols

Protocols summarized from published research models. Provided for scientific reference only — not dosing guidance for human use.

Standard referenceAmount: 1.6 mgFrequency: Twice weeklyRoute: Subcutaneous
Intensive referenceAmount: 1.6 mgFrequency: Daily (short course)Route: Subcutaneous

Observed effects timeline

Aggregated observations reported across research literature. Timing and magnitude vary by model and are not a guarantee of outcome.

  1. Week 1–2

    T-cell maturation and immune-signaling changes reported in study models.

  2. Week 4–12

    Sustained immune-modulating effects reported with continued courses.

Research compatibility

Describes how compounds are studied alongside one another in the literature. Not a recommendation to co-administer.

Thymulin

Overlapping thymic immune mechanisms — avoid redundancy.

Use caution

LL-37

Complementary host-defense pathways.

Compatible

KPV

Distinct anti-inflammatory mechanism.

Compatible

How to reconstitute

Important

Reconstitute with bacteriostatic water, swirl gently, and refrigerate. Avoid shaking to preserve the peptide.

  1. 1Allow the vial to reach room temperature (15–20 minutes).
  2. 2Swab the stopper with alcohol and let it air dry.
  3. 3Add bacteriostatic water slowly down the vial wall.
  4. 4Swirl gently until dissolved into a clear solution.
  5. 5Refrigerate at 2–8 °C and protect from light.
Open reconstitution calculator

Quality indicators

Uniform white powder

Lyophilized cake should be white to off-white without discoloration.

Clear solution

Reconstitutes to a clear, colorless, particle-free solution.

Cold-chain integrity

Reconstituted solution requires 2–8 °C storage.

Slight clumping

Small clumps that dissolve completely with gentle swirling are acceptable — shipping can cause minor compaction.

Collapsed or melted appearance

Powder that looks collapsed, melted, or stuck to the vial walls may have been exposed to heat in transit.

Cloudy after reconstitution

Persistent cloudiness, particles, or precipitate after gentle mixing can indicate a degraded or contaminated peptide.

Reported observations & safety

Safety signals reported in the research literature. Compiled for scientific awareness — not medical advice.

  • Among the best-tolerated and best-validated immune peptides, with substantial clinical use abroad.
  • Injection-site reactions are the most commonly reported signal.

References & further reading

Thymosin alpha-1 immunomodulation (review)

HumanthymalfasinT-cell immunity

Review of thymosin alpha-1's immune-modulating actions and clinical use in hepatitis and as a vaccine adjuvant.

View study

Topics

immunethymict-cell

This entry is provided for educational and informational purposes only. It is not medical advice, a dosing protocol, or a claim of therapeutic benefit. Research compounds are supplied strictly for laboratory and research use — not for human or veterinary consumption.

Research level
Well Researched

Substantial peer-reviewed research across multiple models.

Quick reference
Dose range1.6 mg twice weekly (research models)
RouteSubcutaneous
DurationMulti-week courses
Storage2–8 °C reconstituted
Half-life~2 hours
Catalogue status

This compound is part of our educational reference and is not currently stocked. Browse the catalogue for available research-grade peptides.

Browse catalogue